May 1 |
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
|
Apr 30 |
Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
|
Apr 30 |
Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy
|
Apr 25 |
Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know
|
Apr 24 |
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
Apr 24 |
3 Biotech Stocks With Skyrocketing Potential: April 2024
|
Apr 22 |
10 Best Performing Biotech ETFs in 2024
|
Apr 19 |
How Is The Market Feeling About Intra-Cellular Therapies?
|
Apr 18 |
Intra-Cellular Therapies drops 2%, prices $500M equity financing
|
Apr 18 |
Intra-Cellular Therapies Prices Public Offering of Common Stock
|